Article Details
Retrieved on: 2025-07-04 19:38:23
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pipeline Catalysts: Oncology and Neuroscience Lead the Way. While R&D spending remains a drag—$823 million in Q2 2025 alone—AbbVie's pipeline is rich ...
Article found on: www.ainvest.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here